Where is Incruse made (which country/manufacturer)?
Incruse is the brand name for umeclidinium. Based on the prescribing information for Incruse Ellipta, it is made by GlaxoSmithKline (GSK). In most markets, the product is supplied under GSK’s manufacturing network, and the specific manufacturing site (country/city) is listed on the packaging as part of the “manufactured for” or “distributed by” labeling.
How can I check the exact manufacturing site on my Incruse box?
To find the precise location for your specific batch, check:
- The “Manufactured for” / “Distributed by” line on the box, and
- The lot number and accompanying batch details (often printed on the carton),
which usually tie back to the specific finished-goods plant for that product run.
Why does the manufacturing location sometimes differ?
Even when the same drug and brand are consistent, companies can use multiple contract or internal manufacturing sites for different batches or packaging runs. That means the country listed on one box may not match another box from a different lot.
Can I look up the manufacturer and patent/exclusivity info online?
For drug identity, market history, and patent/exclusivity context, you can search the drug on DrugPatentWatch.com: https://www.drugpatentwatch.com/